LCN2

Chr 9

lipocalin 2

Also known as: 24p3, MSFI, NGAL, p25

This gene encodes a protein that belongs to the lipocalin family. Members of this family transport small hydrophobic molecules such as lipids, steroid hormones and retinoids. The protein encoded by this gene is a neutrophil gelatinase-associated lipocalin and plays a role in innate immunity by limiting bacterial growth as a result of sequestering iron-containing siderophores. The presence of this protein in blood and urine is an early biomarker of acute kidney injury. This protein is thought to be be involved in multiple cellular processes, including maintenance of skin homeostasis, and suppression of invasiveness and metastasis. Mice lacking this gene are more susceptible to bacterial infection than wild type mice. [provided by RefSeq, Sep 2015]

9
Active trials
0
Pathogenic / LP
0
ClinVar variants
7
Pubs (1 yr)
-0.4
Missense Z
1.72
LOEUF
Clinical SummaryLCN2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
💊
Clinical Trials
9 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
1.72LOEUF
pLI 0.000
Z-score -0.35
OE 1.11 (0.721.72)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
-0.43Z-score
OE missense 1.12 (0.961.30)
122 obs / 109.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.1.11 (0.721.72)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.1.12 (0.961.30)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.83
01.21.6
LoF obs/exp: 13 / 11.7Missense obs/exp: 122 / 109.3Syn Z: 0.96
DN
0.6552th %ile
GOF
0.5955th %ile
LOF
0.2582th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

LCN2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

AthletesIronEndurance Performance

Oslo Footballplayers Iron Supplementation and Training (FIT) Study

ACTIVE NOT RECRUITING
NCT04526678Phase NANorwegian University of Life SciencesStarted 2020-08-11
Iron supplement (27mg)
Urinary Tract Infections

DIagnoSing Care hOme UTI Study

RECRUITING
NCT05880329University of SouthamptonStarted 2023-09-01
Candidate POCTs for detecting UTI
Spinal StenosisLigamentum Flavum Hypertrophy

Cytokines, Neuroplasticity Modulators, and Biomarkers in Spinal Canal Stenosis and Endoscopic Decompression

NOT YET RECRUITING
NCT07232836Phase NAPoznan University of Physical EducationStarted 2025-11-17
Endoscopic Spinal Canal Decompression
Viral InfectionSepsis

COMPArative Study of the Consequence on innaTe Immune Response du to Bacterial or Viral Infection in Patients Admitted to Intensive Care Unit

RECRUITING
NCT05671159Phase NAUniversity Hospital, LimogesStarted 2023-02-19
Blood sample
Malnutrition (Calorie)Infant Nutrition DisorderGrowth Flatering

Goat Milk-Derived Formula vs. Undiluted Goat Milk in Infants Unable to Exclusively Breastfeed: Growth and Biomarker Analysis

RECRUITING
NCT07225153Phase NAAga Khan UniversityStarted 2025-08-30
GMDFAUndiluted Goat Milk
Hypertension, Resistant to Conventional Therapy

Antihypertensive Mechanisms of Minocycline in Resistant Hypertension

RECRUITING
NCT06246396Phase PHASE4University of FloridaStarted 2025-01-08
Minocycline HydrochloridePlacebo
Polycystic Ovary SyndromeHypothalamic Amenorrhea

Body Fat as Determinant of Female Gonadal Dysfunction

RECRUITING
NCT03841981Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalStarted 2020-01-31
Anthropometric and physical examinationIndirect calorimetry, accelerometer and seven-day dietary recallBiochemical, hormonal and metabolic phenotyping
Malignant NeoplasmOrgan Damage

Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics

NOT YET RECRUITING
NCT07131007Hebei Medical University Fourth HospitalStarted 2025-08-30
Immunotherapy Monitoring and Sample Collection
Sports NutritionBiochemical MarkersExercise Performance

Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes

RECRUITING
NCT07252778Phase PHASE2, PHASE3Krzysztof Durkalec-MichalskiStarted 2025-11-20
MPRO supplementationPlacebo treatment
Clinical Literature
Landmark / reviewRecent case evidence